These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8973088)

  • 1. Clinical significance of telomerase activity in hepatocellular carcinoma.
    Ohta K; Kanamaru T; Yamamoto M; Saitoh Y
    Kobe J Med Sci; 1996 Jun; 42(3):207-17. PubMed ID: 8973088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telomerase activity in human liver tissues: comparison between chronic liver disease and hepatocellular carcinomas.
    Tahara H; Nakanishi T; Kitamoto M; Nakashio R; Shay JW; Tahara E; Kajiyama G; Ide T
    Cancer Res; 1995 Jul; 55(13):2734-6. PubMed ID: 7796395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Precancerous hepatic nodules had significant levels of telomerase activity determined by sensitive quantitation using a hybridization protection assay.
    Takaishi H; Kitamoto M; Takahashi S; Aikata H; Kawakami Y; Nakanishi T; Nakamura Y; Shimamoto F; Kajiyama G; Ide T
    Cancer; 2000 Jan; 88(2):312-7. PubMed ID: 10640962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical implications of telomerase activity in resected hepatocellular carcinoma.
    Kanamaru T; Yamamoto M; Morita Y; Itoh T; Kuroda Y; Hisatomi H
    Int J Mol Med; 1999 Sep; 4(3):267-71. PubMed ID: 10425277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telomerase as a tool for the differential diagnosis of human hepatocellular carcinoma.
    Nouso K; Urabe Y; Higashi T; Nakatsukasa H; Hino N; Ashida K; Kinugasa N; Yoshida K; Uematsu S; Tsuji T
    Cancer; 1996 Jul; 78(2):232-36. PubMed ID: 8673997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Telomerase activity in liver cancer and the adjacent tissue].
    Fu J; Zhang W; Jin S
    Zhonghua Zhong Liu Za Zhi; 1998 Nov; 20(6):434-6. PubMed ID: 10920937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dihydropyrimidine dehydrogenase and thymidylate synthase activities in hepatocellular carcinomas and in diseased livers.
    Baba H; Teramoto K; Kawamura T; Mori A; Imamura M; Arii S
    Cancer Chemother Pharmacol; 2003 Dec; 52(6):469-76. PubMed ID: 13680162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immuno-histochemical detection of human telomerase reverse transcriptase in human liver tissues.
    Kawakami Y; Kitamoto M; Nakanishi T; Yasui W; Tahara E; Nakayama J; Ishikawa F; Tahara H; Ide T; Kajiyama G
    Oncogene; 2000 Aug; 19(34):3888-93. PubMed ID: 10951582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telomerase activity and telomerase catalytic subunit in hepatocellular carcinoma.
    Lee CM; Hsu CY; Eng HL; Huang WS; Lu SN; Changchien CS; Chen CL; Cho CL
    Hepatogastroenterology; 2004; 51(57):796-800. PubMed ID: 15143919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of telomerase activity in hepatocellular carcinoma.
    Shimada M; Hasegawa H; Gion T; Utsunomiya T; Shirabe K; Takenaka K; Otsuka T; Maehara Y; Sugimachi K
    Am J Gastroenterol; 2000 Mar; 95(3):748-52. PubMed ID: 10710069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telomerase activity in precancerous hepatic nodules.
    Hytiroglou P; Kotoula V; Thung SN; Tsokos M; Fiel MI; Papadimitriou CS
    Cancer; 1998 May; 82(10):1831-8. PubMed ID: 9587114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telomerase activity in hepatocellular carcinoma as a predictor of postoperative recurrence.
    Ohta K; Kanamaru T; Morita Y; Hayashi Y; Ito H; Yamamoto M
    J Gastroenterol; 1997 Dec; 32(6):791-6. PubMed ID: 9430018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomerase activity, telomere length and human telomerase reverse transcriptase expression in hepatocellular carcinoma is independent of hepatitis virus status.
    Saini N; Srinivasan R; Chawla Y; Sharma S; Chakraborti A; Rajwanshi A
    Liver Int; 2009 Sep; 29(8):1162-70. PubMed ID: 19627485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telomerase reverse transcriptase gene amplification in hepatocellular carcinoma.
    Takuma Y; Nouso K; Kobayashi Y; Nakamura S; Tanaka H; Matsumoto E; Fujikawa T; Suzuki M; Hanafusa T; Shiratori Y
    J Gastroenterol Hepatol; 2004 Nov; 19(11):1300-4. PubMed ID: 15482538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal expression of hepatomas and circulating telomerase and its clinical values.
    Wu W; Yao DF; Qiu LW; Wu XH; Yao M; Su XQ; Zou L
    Hepatobiliary Pancreat Dis Int; 2005 Nov; 4(4):544-9. PubMed ID: 16286259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of telomerase-associated protein 1 and telomerase reverse transcriptase in hepatocellular carcinoma.
    Toshikuni N; Nouso K; Higashi T; Nakatsukasa H; Onishi T; Kaneyoshi T; Kobayashi Y; Kariyama K; Yamamoto K; Tsuji T
    Br J Cancer; 2000 Feb; 82(4):833-7. PubMed ID: 10732755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telomerase activity and Nm23-H2 protein expression in hepatocellular carcinoma.
    Iizuka N; Mori N; Tamesa T; Tangoku A; Oka M
    Anticancer Res; 2003; 23(1A):43-7. PubMed ID: 12680194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thymidine phosphorylase activity in liver tissue and its correlation with multifocal occurrence of hepatocellular carcinomas.
    Ikeguchi M; Sakatani T; Ueda T; Hirooka Y; Kaibara N
    In Vivo; 2001; 15(4):265-70. PubMed ID: 11695216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Telomere length and telomerase activity in hepatocellular carcinoma].
    Nakashio R; Kitamoto M; Nakanishi T; Takaishi H; Takahashi S; Kajiyama G
    Nihon Rinsho; 1998 May; 56(5):1239-43. PubMed ID: 9613130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telomerase in hepatocellular carcinogenesis.
    Ide T; Tahara H; Nakashio R; Kitamoto M; Nakanishi T; Kajiyama G
    Hum Cell; 1996 Dec; 9(4):283-6. PubMed ID: 9183659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.